Cargando…
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma
SIMPLE SUMMARY: Even with recent advances, there are urgent needs for novel therapies to improve overall survival and decrease toxicities in the management of head and neck squamous cell carcinoma (HNSCC). This article reviews historical data to provide a context and highlights recent data in unders...
Autores principales: | Muzaffar, Jameel, Bari, Shahla, Kirtane, Kedar, Chung, Christine H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831487/ https://www.ncbi.nlm.nih.gov/pubmed/33477635 http://dx.doi.org/10.3390/cancers13020338 |
Ejemplares similares
-
Postoperative Combined Modality Treatment in High Risk Resected Locally Advanced Squamous Cell Carcinomas of the Head and Neck (HNSCC)
por: Kirtane, Kedar, et al.
Publicado: (2018) -
T cell repertoire in peripheral blood as a potential biomarker for predicting response to concurrent cetuximab and nivolumab in head and neck squamous cell carcinoma
por: Wang, Xuefeng, et al.
Publicado: (2022) -
Combination targeted and immune therapy in the treatment of advanced melanoma: a valid treatment option for patients?
por: Bari, Shahla, et al.
Publicado: (2022) -
“I have cancer during COVID; that’s a special category”: a qualitative study of head and neck cancer patient and provider experiences during the COVID-19 pandemic
por: Kirtane, Kedar, et al.
Publicado: (2022) -
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
por: Haddad, R I, et al.
Publicado: (2018)